2004
DOI: 10.1016/j.bbrc.2004.04.066
|View full text |Cite
|
Sign up to set email alerts
|

Aryl hydrocarbon receptor-mediated induction of microsomal drug-metabolizing enzyme activity by indirubin and indigo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
41
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 66 publications
(43 citation statements)
references
References 28 publications
2
41
0
Order By: Relevance
“…Antitumor activity of 7-bromoindirubin-3 0 -oxime J Ribas et al (Adachi et al, 2001;Spink et al, 2003;Knockaert et al, 2004;Sugihara et al, 2004). 7-Bromoindirubin-3 0 -oxime clearly activates AhR as observed in an in vitro luciferase reporter system (unpublished), and confirmed by the AhR-dependent expression of p27…”
Section: Discussionmentioning
confidence: 82%
“…Antitumor activity of 7-bromoindirubin-3 0 -oxime J Ribas et al (Adachi et al, 2001;Spink et al, 2003;Knockaert et al, 2004;Sugihara et al, 2004). 7-Bromoindirubin-3 0 -oxime clearly activates AhR as observed in an in vitro luciferase reporter system (unpublished), and confirmed by the AhR-dependent expression of p27…”
Section: Discussionmentioning
confidence: 82%
“…Indigo and indirubin have been identified in human urine and found to be potent activators of AHR (Adachi et al, 2001;Peter Guengerich et al, 2004;Sugihara et al, 2004). Indirubin was found to be a more potent human AHR agonist when compared with the murine Ah b-1 allele (high affinity for TCDD) of the receptor .…”
Section: Host Metabolism Of Indolesmentioning
confidence: 99%
“…Indirubin and its derivatives bind to and inhibit cyclin-dependent kinase (CDK) 3 1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, and CDK5/p25, displaying potent growth inhibitory effects in various human tumors (9 -12). Additionally, indirubin derivatives bind to and inhibit glycogen synthase kinase-3␤ (13)(14)(15), c-Src kinase (16), aryl hydrocarbon receptor (17,18), and rabbit muscle glycogen phosphorylase b (19). More recently indirubin was shown to inhibit c-Jun NH 2 -terminal kinase (20).…”
mentioning
confidence: 99%